A nation-wide twin study of social cognition in schizophrenia spectrum disorders

por Lemvigh, Cecilie K., Glenthøj, Birte Y., Fagerlund, Birgitte
Publicado 2022

Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics

por Nejad, Ayna B, Ebdrup, Bjørn H, Glenthøj, Birte Y, Siebner, Hartwig R
Publicado 2012

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

por Rasmussen, Jesper Østrup, Jennum, Poul, Linnet, Kristian, Glenthøj, Birte Y., Baandrup, Lone
Publicado 2021

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia

por Bak, Nikolaj, Rostrup, Egill, Larsson, Henrik B.W., Glenthøj, Birte Y., Oranje, Bob
Publicado 2013

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses

por Nielsen, Mette Ødegaard, Kristensen, Tina Dam, Borup Bojesen, Kirsten, Glenthøj, Birte Y., Lemvigh, Cecilie K., Ebdrup, Bjørn H.
Publicado 2022

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol

por Baandrup, Lone, Fagerlund, Birgitte, Jennum, Poul, Lublin, Henrik, Hansen, Jane L, Winkel, Per, Gluud, Christian, Oranje, Bob, Glenthoj, Birte Y
Publicado 2011

The impact of schizophrenia and intelligence on the relationship between age and brain volume

por Jensen, Maria H., Bak, Nikolaj, Rostrup, Egill, Nielsen, Mette Ø., Pantelis, Christos, Glenthøj, Birte Y., Ebdrup, Bjørn H., Fagerlund, Birgitte
Publicado 2018

F176. CLINICAL CORRELATES OF CORTICAL STRUCTURE IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER SIX-WEEK TREATMENT WITH A DOPAMINE D2/3 RECEPTOR ANTAGONIST

por Jessen, Kasper, Rostrup, Egill, Mandl, Rene C W, Nielsen, Mette Ø, Bak, Nikolaj, Fagerlund, Birgitte, Glenthøj, Birte Y, Ebdrup, Bjørn H
Publicado 2018

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis

por Myken, Anders N, Ebdrup, Bjørn H, Sørensen, Mikkel E, Broberg, Brian V, Skjerbæk, Martin W, Glenthøj, Birte Y, Lykkesfeldt, Jens, Nielsen, Mette Ø
Publicado 2022

Frontal D(2/3) Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology

por Nørbak-Emig, Henrik, Ebdrup, Bjørn H., Fagerlund, Birgitte, Svarer, Claus, Rasmussen, Hans, Friberg, Lars, Allerup, Peter N., Rostrup, Egill, Pinborg, Lars H., Glenthøj, Birte Y.
Publicado 2016

Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial

por Ishøy, Pelle L., Knop, Filip K., Broberg, Brian V., Bak, Nikolaj, Andersen, Ulrik B., Jørgensen, Niklas R., Holst, Jens J., Glenthøj, Birte Y., Ebdrup, Bjørn H.
Publicado 2016

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients

por Ebdrup, Bjørn H., Axelsen, Martin C., Bak, Nikolaj, Fagerlund, Birgitte, Oranje, Bob, Raghava, Jayachandra M., Nielsen, Mette Ø., Rostrup, Egill, Hansen, Lars K., Glenthøj, Birte Y.
Publicado 2019

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded inter...

por Ishøy, Pelle L, Knop, Filip K, Broberg, Brian V, Baandrup, Lone, Fagerlund, Birgitte, Jørgensen, Niklas R, Andersen, Ulrik B, Rostrup, Egill, Glenthøj, Birte Y, Ebdrup, Bjørn H
Publicado 2014

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis

por Bojesen, Kirsten B., Ebdrup, Bjørn H., Jessen, Kasper, Sigvard, Anne, Tangmose, Karen, Edden, Richard A.E., Larsson, Henrik B.W., Rostrup, Egill, Broberg, Brian V., Glenthøj, Birte Y.
Publicado 2020

Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment

por Dahl, Anne Sofie A., Sørensen, Victor, Ambrosen, Karen S., Sørensen, Mikkel E., Mohr, Grímur H., Nielsen, Mette Ø., Bojesen, Kirsten B., Glenthøj, Birte Y., Hahn, Margaret, Midtgaard, Julie, Ebdrup, Bjørn H.
Publicado 2023

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol

por Baltzersen, Olga B., Meltzer, Herbert Y., Frokjaer, Vibe G., Raghava, Jayachandra M., Baandrup, Lone, Fagerlund, Birgitte, Larsson, Henrik B.W., Fibiger, H. Christian, Glenthøj, Birte Y., Knudsen, Gitte M., Ebdrup, Bjørn H.
Publicado 2020

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis

por Rasmussen, Jesper Ø., Nordholm, Dorte, Glenthøj, Louise B., Jensen, Marie A., Garde, Anne H., Ragahava, Jayachandra M., Jennum, Poul J., Glenthøj, Birte Y., Nordentoft, Merete, Baandrup, Lone, Ebdrup, Bjørn H., Kristensen, Tina D.
Publicado 2022

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL

por Kristensen, Tina, Ebdrup, Bjørn H, Hjorthøj, Carsten, Mandl, Rene C W, Mitta Raghava, Jayachandra, Møllegaard Jepsen, Jens Richardt, Fagerlund, Birgitte, Glenthøj, Louise B, Wenneberg, Christina, Krakauer, Kristine, Pantelis, Christos, Glenthøj, Birte Y, Nordentoft, Merete
Publicado 2020

Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis

por Kristensen, Tina D., Mandl, René C. W., Raghava, Jayachandra M., Jessen, Kasper, Jepsen, Jens Richardt M., Fagerlund, Birgitte, Glenthøj, Louise B., Wenneberg, Christina, Krakauer, Kristine, Pantelis, Christos, Nordentoft, Merete, Glenthøj, Birte Y., Ebdrup, Bjørn H.
Publicado 2019

Striatal Volume Increase After Six Weeks of Selective Dopamine D(2/3) Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients

por Andersen, Helle G., Raghava, Jayachandra M., Svarer, Claus, Wulff, Sanne, Johansen, Louise B., Antonsen, Patrick K., Nielsen, Mette Ø., Rostrup, Egill, Vernon, Anthony C., Jensen, Lars T., Pinborg, Lars H., Glenthøj, Birte Y., Ebdrup, Bjørn H.
Publicado 2020